Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
94.6 EUR
-3.86%
Market Closed
Updated:
May 22, 2024
Gerresheimer AG
Operating Expenses
|
Gerresheimer AG
Operating Expenses Peer Comparison
Comparables:
E
EVT
S
1SXP
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gerresheimer AG
XETRA:GXI
|
Operating Expenses
-€378.6m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-5%
|
|
E
|
Evotec SE
XETRA:EVT
|
Operating Expenses
-€217.5m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-23%
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Operating Expenses
-€145.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Operating Expenses?
Operating Expenses
-378.6m
EUR
-378.6m
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Operating Expenses amounts to -378.6m EUR.
What is Gerresheimer AG's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%
-5%
Over the last year, the Operating Expenses growth was 6%. The average annual Operating Expenses growth rates for Gerresheimer AG have been -11% over the past three years , -8% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
